Teysuno
Marketing campaign to promote Teysuno, an oral chemotherapy medication used to treat advanced gastric (stomach) cancer in combination with cisplatin, and for metastatic colorectal cancer
Software
Illustrator
Client
Teysuno
Services
Design
Project
Creative
Description
The brief was to develop a marketing campaign for Teysuno, an oral chemotherapy treatment used in combination with cisplatin for advanced gastric (stomach) cancer and metastatic colorectal cancer. A key focus of the campaign was to communicate the treatment’s ability to help reduce the risk of cardiotoxicity and hand-foot syndrome related interruptions, while presenting the therapy in a more human and emotionally engaging way.
The creative direction centred around the idea of connection, comfort and reclaiming everyday moments. Rather than focusing solely on the clinical and scientific aspects of treatment, the campaign aimed to highlight the importance of quality of life and the simple human experiences that can often be impacted by invasive cancer treatments. Warm, authentic interactions between people became the emotional core of the campaign, symbolising reassurance, closeness and the ability to maintain meaningful moments without the burden of debilitating side effects.
Visually, the campaign moved away from traditional pharmaceutical aesthetics and instead embraced a more lifestyle-driven and patient-focused approach. A bright, optimistic colour palette was introduced to create warmth and positivity, while bold typography helped reinforce key messaging with clarity and confidence. Carefully selected patient imagery added emotional depth and relatability, helping the campaign feel approachable, compassionate and supportive.
The final campaign delivered a strong balance between emotional storytelling and medical communication, creating a visually impactful identity that could be adapted across a range of marketing materials, including digital communications, printed collateral, healthcare congress materials and wider promotional assets. The result was a campaign that not only communicated the clinical benefits of Teysuno, but also reflected the human side of cancer treatment and patient care.